Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
106 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
1 Recruiting Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
Condition: Carcinoma, Ductal, Breast
Interventions: Radiation: Standard WB fractionation;   Radiation: Shorter WB fractionation;   Radiation: Standard WB fractionation+Boost;   Radiation: Shorter WB fractionation + Boost
2 Unknown  Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Condition: Ductal Carcinoma In Situ
Interventions: Drug: Carboplatin i.d. Days 1 & 15;   Drug: Carboplatin i.d. Day 1; Normal Saline i.d. Day 15;   Drug: Normal Saline
3 Recruiting A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Dietary Supplement: Black cohosh
4 Recruiting Effects of Diet and Exercise on Ductal Carcinoma in Situ
Conditions: Ductal Carcinoma In Situ (DCIS);   Breast Cancer (Stage 0)
Interventions: Behavioral: Active Comparator: Progressive Resistance Training (PRT) and a healthy diet;   Behavioral: Experimental: PRT and a healthy diet, plus weight loss
5 Recruiting A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Drug: Polyphenon E
6 Recruiting A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Behavioral: The risk assessment questionnaire;   Other: Blood specimens;   Other: tumor tissue samples will be requested
7 Recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Condition: Ductal Breast Carcinoma In Situ
Interventions: Biological: Trastuzumab;   Radiation: Whole Breast Irradiation;   Other: Laboratory Biomarker Analysis
8 Recruiting Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Momelotinib;   Drug: Placebo to match momelotinib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
9 Recruiting Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MMB;   Drug: Capecitabine;   Drug: Oxaliplatin
10 Unknown  Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Condition: Non-curative Resectable Bile Duct Carcinoma
Intervention: Drug: Temoporfin
11 Recruiting Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Condition: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Intervention: Dietary Supplement: Vitamin D
12 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy
13 Recruiting Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Drug: Intranasal Oxytocin
14 Not yet recruiting Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Ductal Breast Carcinoma With Predominant Intraductal Component;   Lobular Breast Carcinoma in Situ;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Tubular Ductal Breast Carcinoma
Interventions: Radiation: accelerated partial breast irradiation;   Radiation: intensity-modulated radiation therapy;   Radiation: image-guided radiation therapy;   Procedure: therapeutic conventional surgery;   Other: questionnaire administration;   Other: laboratory biomarker analysis
15 Recruiting Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Conditions: Inflammatory Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Tubular Ductal Breast Carcinoma
Intervention: Radiation: External beam radiation therapy
16 Recruiting Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: Mammosite ML
17 Recruiting Plasma Biomarkers P-DAC, V1
Condition: Pancreatic Ductal Adenocarcinoma
Intervention:
18 Recruiting Intraoperative Imaging of Breast Cancer With Indocyanine Green
Conditions: Invasive Ductal Carcinoma;   Invasive Lobular Carcinoma;   Ductal Carcinoma
Intervention: Drug: Indocyanine Green
19 Recruiting Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: PTP-01
20 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years